Aadi Bioscience, Inc. (WHWK) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aadi Bioscience, Inc. (WHWK:NASDAQ), powered by AI.
- Current Price
- $4.17
- P/E Ratio
- -12.5
- Market Cap
- 258M
- Sector
- Healthcare
What is the Aadi Bioscience, Inc. stock price forecast?
Aadi Bioscience, Inc. is currently trading at $4.17. View real-time AI analysis on Alpha Lenz.
What is Aadi Bioscience, Inc. insider trading activity?
View the latest insider trading data for Aadi Bioscience, Inc. on Alpha Lenz.
What is Aadi Bioscience, Inc.'s P/E ratio?
Aadi Bioscience, Inc.'s P/E ratio is -12.5.
Aadi Bioscience, Inc.
NASDAQ · WHWK“Aadi Bioscience, Inc. trades at a P/E of -12.5 (undervalued) with modest ROE of -21.8%.”
Ask for details →Company Overview
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Aadi Bioscience, Inc. trades at a P/E of -12.5 (undervalued) with modest ROE of -21.8%.”
Ask for details →Frequently Asked Questions
Aadi Bioscience, Inc. (ticker: WHWK) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 21 employees. Market cap is $258M.
The current price is $4.17 with a P/E ratio of -12.53x and P/B of 1.89x.
ROE is -21.82% and operating margin is -1601.12%. Annual revenue is $7M.